Published 2020
| Version v1
Publication
Why not consider an endothelin receptor antagonist against SARS‐CoV‐2?
- Creators
- Javor S.
- Salsano A.
- Others:
- Javor, S.
- Salsano, A.
Additional details
- URL
- http://hdl.handle.net/11567/1008090
- URN
- urn:oai:iris.unige.it:11567/1008090
- Origin repository
- UNIGE